Multicentre Hypertrophic Cardiomyopathy Registry

Abroad (travel likely)Recruiting

Conditions

Hypertrophic Cardiomyopathy (HCM)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Manchester, Manchester, United Kingdom
Contact: Study coordinator (Andrew Crean) · hcmresearch@manchester.ac.uk · +441619987070

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Effectiveness and Treatment Patterns of Mavacamten in Patients With Obstructive Hypertrophic Cardiomyopathy in Japan (MANAGE-HCM)

Cardiomyopathy

Abroad (travel likely)Recruiting

Minato-ku, Japan

Pediatric Cardiomyopathy Mutation Analysis

Cardiomyopathies · Dilated Cardiomyopathy · Hypertrophic Cardiomyopathy

Abroad (travel likely)Recruiting

Indianapolis, United States

A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy in China

Hypertrophic Cardiomyopathy

Abroad (travel likely)Recruiting

Beijing, China · Beijing, China

Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM

Hypertrophic Cardiomyopathy

Abroad (travel likely)RecruitingPHASE1, PHASE2

La Jolla, United States · San Francisco, United States